Latest News
From the Journals
Statins appear to guard against liver disease progression
This study “continues the theme that cholesterol-lowering statins are good for a lot more things than just lowering cholesterol.”
Latest News
FDA approves new drug to manage menopausal hot flashes
Fezolinetant (Veozah) targets the neural activity behind moderate to severe vasomotor symptoms.
From the Journals
CGM completes picture of A1c in type 2 diabetes
“This may help empower people with diabetes to better manage their condition, giving them practical insights into the factors driving daily...
Conference Coverage
BMI has greater impact on survival in younger breast cancer patients
Study of women on endocrine therapy for breast cancer addresses the effects of BMI on survival.
Conference Coverage
Endoscopic sleeve gastroplasty plus obesity drugs add up to more weight loss
Some experts believe weight-loss medications can help with the rebound in weight that some people experience months after bariatric surgery.
From the Journals
Early gestational diabetes treatment may improve neonatal outcomes
No differences were observed in pregnancy-related hypertension or neonatal lean body mass.
From the Journals
Number of cancer survivors with functional limitations doubled in 20 years
The 70% prevalence of functional limitation among survivors in 2018 is nearly twice that of the general population.
From the Journals
Risk assessment first urged for fragility fracture screening
A new guideline is aimed at primary care practitioners for their community-dwelling patients aged 40 and older.
Latest News
Medical students gain momentum in effort to ban legacy admissions
Opponents of legacy admissions say it penalizes students from racial minorities and lower socioeconomic backgrounds, hampering a fair and...
Latest News
Five ways docs may qualify for discounts on medical malpractice premiums
Most states cap discounts at 25%, but some go as high as 70%.
Conference Coverage
New protocol could cut fasting period to detect insulinomas
“These data support a 48-hour fast. The literature supports that’s sufficient to detect 95% of insulinomas.”